KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Eli Lilly (LLY) Dividends payables (2016 - 2025)

Eli Lilly filings provide 17 years of Dividends payables readings, the most recent being $1.3 billion for Q2 2025.

  • On a quarterly basis, Dividends payables rose 14.93% to $1.3 billion in Q2 2025 year-over-year; TTM through Jun 2025 was $1.3 billion, a 14.93% increase, with the full-year FY2024 number at $1.3 billion, up 15.15% from a year prior.
  • Dividends payables hit $1.3 billion in Q2 2025 for Eli Lilly, roughly flat from $1.3 billion in the prior quarter.
  • In the past five years, Dividends payables ranged from a high of $1.3 billion in Q4 2024 to a low of $770.8 million in Q2 2021.
  • Median Dividends payables over the past 5 years was $1.0 billion (2022), compared with a mean of $1.1 billion.
  • Biggest five-year swings in Dividends payables: rose 14.45% in 2022 and later increased 15.19% in 2023.
  • Eli Lilly's Dividends payables stood at $885.5 million in 2021, then grew by 14.87% to $1.0 billion in 2022, then increased by 14.94% to $1.2 billion in 2023, then grew by 15.15% to $1.3 billion in 2024, then dropped by 0.08% to $1.3 billion in 2025.
  • The last three reported values for Dividends payables were $1.3 billion (Q2 2025), $1.3 billion (Q4 2024), and $1.2 billion (Q2 2024) per Business Quant data.